{"id":"https://openalex.org/W2789631298","doi":"https://doi.org/10.1158/1538-7445.sabcs17-ot1-01-02","title":"Abstract OT1-01-02: A multicenter phase II trial to evaluate the efficacy and safety of pembrolizumab and gemcitabine in patients with HER2-negative advanced breast cancer: GEICAM/2015-04 PANGEA-Breast","display_name":"Abstract OT1-01-02: A multicenter phase II trial to evaluate the efficacy and safety of pembrolizumab and gemcitabine in patients with HER2-negative advanced breast cancer: GEICAM/2015-04 PANGEA-Breast","publication_year":2018,"publication_date":"2018-02-15","ids":{"openalex":"https://openalex.org/W2789631298","doi":"https://doi.org/10.1158/1538-7445.sabcs17-ot1-01-02","mag":"2789631298"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs17-ot1-01-02","doi":"https://doi.org/10.1158/1538-7445.sabcs17-ot1-01-02","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs17-ot1-01-02","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014613098","display_name":"Luis de la Cruz\u2010Merino","orcid":"https://orcid.org/0000-0002-5333-0535","observed_orcids":["https://orcid.org/0000-0002-5333-0535"]},"institutions":[{"id":"https://openalex.org/I4210090436","display_name":"Hospital Universitario Virgen Macarena","ror":"https://ror.org/016p83279","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210090436"]},{"id":"https://openalex.org/I4210163263","display_name":"GEICAM \u2013 Spanish Breast Cancer Group","ror":"https://ror.org/05ygm7711","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210163263"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]},{"id":"https://openalex.org/I4392738196","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada","ror":"https://ror.org/01qew8q20","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]}],"countries":["ES","FR"],"is_corresponding":false,"raw_author_name":"L de la Cruz","raw_affiliation_strings":["Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","GEICAM Spanish Breast Cancer Group, Madrid, Spain","Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263","https://openalex.org/I4387156284","https://openalex.org/I4392738196"]},{"raw_affiliation_string":"GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210163263"]},{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038461805","display_name":"V\u00edctor S\u00e1nchez\u2010Margalet","orcid":"https://orcid.org/0000-0001-8638-8680","observed_orcids":["https://orcid.org/0000-0001-8638-8680"]},"institutions":[{"id":"https://openalex.org/I4210090436","display_name":"Hospital Universitario Virgen Macarena","ror":"https://ror.org/016p83279","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210090436"]},{"id":"https://openalex.org/I4210163263","display_name":"GEICAM \u2013 Spanish Breast Cancer Group","ror":"https://ror.org/05ygm7711","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210163263"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]},{"id":"https://openalex.org/I4392738196","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada","ror":"https://ror.org/01qew8q20","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]}],"countries":["ES","FR"],"is_corresponding":false,"raw_author_name":"V S\u00e1nchez-Margalet","raw_affiliation_strings":["Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","GEICAM Spanish Breast Cancer Group, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263","https://openalex.org/I4387156284","https://openalex.org/I4392738196"]},{"raw_affiliation_string":"GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210163263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064978271","display_name":"Pedro Berraondo","orcid":"https://orcid.org/0000-0001-7410-1865","observed_orcids":["https://orcid.org/0000-0001-7410-1865"]},"institutions":[{"id":"https://openalex.org/I4210090436","display_name":"Hospital Universitario Virgen Macarena","ror":"https://ror.org/016p83279","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210090436"]},{"id":"https://openalex.org/I4210163263","display_name":"GEICAM \u2013 Spanish Breast Cancer Group","ror":"https://ror.org/05ygm7711","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210163263"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]},{"id":"https://openalex.org/I4392738196","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada","ror":"https://ror.org/01qew8q20","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]}],"countries":["ES","FR"],"is_corresponding":false,"raw_author_name":"P Berraondo","raw_affiliation_strings":["Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","GEICAM Spanish Breast Cancer Group, Madrid, Spain","Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263","https://openalex.org/I4387156284","https://openalex.org/I4392738196"]},{"raw_affiliation_string":"GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210163263"]},{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077598630","display_name":"Sara Benito","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090436","display_name":"Hospital Universitario Virgen Macarena","ror":"https://ror.org/016p83279","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210090436"]},{"id":"https://openalex.org/I4210163263","display_name":"GEICAM \u2013 Spanish Breast Cancer Group","ror":"https://ror.org/05ygm7711","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210163263"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]},{"id":"https://openalex.org/I4392738196","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada","ror":"https://ror.org/01qew8q20","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]}],"countries":["ES","FR"],"is_corresponding":false,"raw_author_name":"S Benito","raw_affiliation_strings":["Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","GEICAM Spanish Breast Cancer Group, Madrid, Spain","Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263","https://openalex.org/I4387156284","https://openalex.org/I4392738196"]},{"raw_affiliation_string":"GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210163263"]},{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263"]}]},{"author_position":"middle","author":{"id":null,"display_name":"MJ Escudero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090436","display_name":"Hospital Universitario Virgen Macarena","ror":"https://ror.org/016p83279","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210090436"]},{"id":"https://openalex.org/I4210163263","display_name":"GEICAM \u2013 Spanish Breast Cancer Group","ror":"https://ror.org/05ygm7711","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210163263"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]},{"id":"https://openalex.org/I4392738196","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada","ror":"https://ror.org/01qew8q20","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]}],"countries":["ES","FR"],"is_corresponding":false,"raw_author_name":"MJ Escudero","raw_affiliation_strings":["Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","GEICAM Spanish Breast Cancer Group, Madrid, Spain","Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263","https://openalex.org/I4387156284","https://openalex.org/I4392738196"]},{"raw_affiliation_string":"GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210163263"]},{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075937719","display_name":"Rosal\u00eda Caballero","orcid":"https://orcid.org/0000-0002-6027-1748","observed_orcids":["https://orcid.org/0000-0002-6027-1748"]},"institutions":[{"id":"https://openalex.org/I4210090436","display_name":"Hospital Universitario Virgen Macarena","ror":"https://ror.org/016p83279","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210090436"]},{"id":"https://openalex.org/I4210163263","display_name":"GEICAM \u2013 Spanish Breast Cancer Group","ror":"https://ror.org/05ygm7711","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210163263"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]},{"id":"https://openalex.org/I4392738196","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada","ror":"https://ror.org/01qew8q20","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]}],"countries":["ES","FR"],"is_corresponding":false,"raw_author_name":"R Caballero","raw_affiliation_strings":["Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","GEICAM Spanish Breast Cancer Group, Madrid, Spain","Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263","https://openalex.org/I4387156284","https://openalex.org/I4392738196"]},{"raw_affiliation_string":"GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210163263"]},{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039927103","display_name":"Eva Carrasco","orcid":"https://orcid.org/0000-0002-2771-7197","observed_orcids":["https://orcid.org/0000-0002-2771-7197"]},"institutions":[{"id":"https://openalex.org/I4210090436","display_name":"Hospital Universitario Virgen Macarena","ror":"https://ror.org/016p83279","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210090436"]},{"id":"https://openalex.org/I4210163263","display_name":"GEICAM \u2013 Spanish Breast Cancer Group","ror":"https://ror.org/05ygm7711","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210163263"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]},{"id":"https://openalex.org/I4392738196","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada","ror":"https://ror.org/01qew8q20","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]}],"countries":["ES","FR"],"is_corresponding":false,"raw_author_name":"E Carrasco","raw_affiliation_strings":["Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","GEICAM Spanish Breast Cancer Group, Madrid, Spain","Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263","https://openalex.org/I4387156284","https://openalex.org/I4392738196"]},{"raw_affiliation_string":"GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210163263"]},{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071827163","display_name":"Lorenzo Galluzzi","orcid":"https://orcid.org/0000-0003-2257-8500","observed_orcids":["https://orcid.org/0000-0003-2257-8500"]},"institutions":[{"id":"https://openalex.org/I4210090436","display_name":"Hospital Universitario Virgen Macarena","ror":"https://ror.org/016p83279","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210090436"]},{"id":"https://openalex.org/I4210163263","display_name":"GEICAM \u2013 Spanish Breast Cancer Group","ror":"https://ror.org/05ygm7711","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210163263"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]},{"id":"https://openalex.org/I4392738196","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada","ror":"https://ror.org/01qew8q20","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]}],"countries":["ES","FR"],"is_corresponding":false,"raw_author_name":"L Galluzzi","raw_affiliation_strings":["Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","GEICAM Spanish Breast Cancer Group, Madrid, Spain","Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263","https://openalex.org/I4387156284","https://openalex.org/I4392738196"]},{"raw_affiliation_string":"GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210163263"]},{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012974257","display_name":"Federico Rojo","orcid":"https://orcid.org/0000-0001-9989-0290","observed_orcids":["https://orcid.org/0000-0001-9989-0290"]},"institutions":[{"id":"https://openalex.org/I4210090436","display_name":"Hospital Universitario Virgen Macarena","ror":"https://ror.org/016p83279","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210090436"]},{"id":"https://openalex.org/I4210163263","display_name":"GEICAM \u2013 Spanish Breast Cancer Group","ror":"https://ror.org/05ygm7711","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210163263"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]},{"id":"https://openalex.org/I4392738196","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada","ror":"https://ror.org/01qew8q20","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]}],"countries":["ES","FR"],"is_corresponding":false,"raw_author_name":"F Rojo","raw_affiliation_strings":["Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","GEICAM Spanish Breast Cancer Group, Madrid, Spain","Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain; Centro de Investigaci\u00f3n Medica Aplicada (CIMA), Pamplona, Spain; GEICAM Spanish Breast Cancer Group, Madrid, Spain; Weill Cornell Medical College, Sandra and Edward Meyer Cancer Center, Universit\u00e9 Paris Descartes/Paris V, NY; IIS-Fundacion Jimenez Diaz-UAM. GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263","https://openalex.org/I4387156284","https://openalex.org/I4392738196"]},{"raw_affiliation_string":"GEICAM Spanish Breast Cancer Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210163263"]},{"raw_affiliation_string":"Hospital Universitario Virgen de la Macarena, GEICAM Spanish Breast Cancer Group, Sevilla, Spain","institution_ids":["https://openalex.org/I4210090436","https://openalex.org/I4210163263"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"4_Supplement","first_page":"OT1","last_page":"01"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7178000211715698,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.7178000211715698,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.14790000021457672,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.10109999775886536,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":1.0},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.8619999885559082},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.8220000267028809},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.8830000162124634},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6679999828338623},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6039999723434448},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.7559999823570251},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8629999756813049},{"id":"https://openalex.org/keywords/immunological-biomarkers","display_name":"immunological biomarkers","score":0.6700000166893005},{"id":"https://openalex.org/keywords/heavily-pretreated-patients","display_name":"heavily pretreated patients","score":0.6589999794960022},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5519999861717224},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7480000257492065},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.6399999856948853}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8992897272109985},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7623701691627502},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7258098125457764},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7180467844009399},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.68690025806427},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6337434649467468},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5961360335350037},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.550951361656189},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4807055592536926},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4641410708427429},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4199317991733551},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4102988839149475},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3648555874824524},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.30173787474632263},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.19048258662223816}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs17-ot1-01-02","doi":"https://doi.org/10.1158/1538-7445.sabcs17-ot1-01-02","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs17-ot1-01-02","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2995904510","https://openalex.org/W2903875264","https://openalex.org/W4311202775","https://openalex.org/W3209938970","https://openalex.org/W3145016065","https://openalex.org/W2395760636","https://openalex.org/W2243139147","https://openalex.org/W2403705203","https://openalex.org/W2735059932","https://openalex.org/W4249380943"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Treatment":[2,151],"options":[3],"for":[4,26,264,325,356,419],"advanced":[5,476],"breast":[6,477],"cancer":[7],"(ABC)":[8],"are":[9,24,117,145,196,209,274,294,305,323,354],"multiple":[10],"but":[11,33],"unable":[12],"to":[13,16,74,102,462],"properly":[14],"respond":[15],"current":[17],"clinical":[18,72,108,234,286],"needs.":[19],"In":[20,170],"particular,":[21],"improved":[22],"therapies":[23],"needed":[25],"triple":[27],"negative":[28,432],"and":[29,82,127,129,163,168,191,211,225,227,241,251,279,282,288,300,311,327,333,342,346,367,372,411,416,466,470],"hormone":[30,136],"receptor":[31],"(HR)-positive":[32],"heavily":[34],"pretreated":[35],"patients.":[36,94],"Pembrolizumab":[37,433],"(P)":[38],"is":[39,57,246,254,405],"a":[40,58,177,390],"human":[41],"monoclonal":[42],"antibody":[43],"that":[44,97],"blocks":[45],"the":[46,76,83,86,171,217,257,408,425,464,485],"PD-1/PD-L1":[47],"interaction":[48],"hence":[49],"potentiates":[50],"anticancer":[51],"T":[52],"cell":[53,360],"responses.":[54],"Gemcitabine":[55],"(G)":[56],"cytotoxic":[59],"drug":[60],"with":[61,105,125,142,156,181,284,387,474],"well-known":[62],"immunostimulatory":[63],"properties.":[64],"Here,":[65],"we":[66,175],"report":[67],"an":[68],"ongoing":[69],"phase":[70,459],"II":[71,79,460],"trial":[73,461],"identify":[75],"Recommended":[77],"Phase":[78],"Dose":[80],"(RP2D)":[81],"efficacy":[84,229,287,465],"of":[85,88,135,153,186,216,223,365,374,392,397,414,424,468,484],"combination":[87],"these":[89,98],"two":[90,130],"agents":[91,99],"in":[92,276,339,422,472],"ABC":[93,119],"We":[95],"hypothesize":[96],"may":[100],"synergize":[101],"induce":[103],"responses":[104],"long":[106],"term":[107],"benefit":[109,235],"(ClinicalTrials.gov":[110],"Identifier:":[111],"NCT03025880).":[112],"Trial":[113],"Design:":[114],"Eligible":[115],"patients":[116,120,399,473],"HER2-negative":[118,475],"who":[121],"received":[122],"prior":[123,133],"treatment":[124],"anthracyclines":[126],"taxanes":[128],"or":[131,200,203,314],"more":[132],"lines":[134],"therapy,":[137],"if":[138,148],"HR-positive":[139],"disease.":[140],"Patients":[141,195],"CNS":[143],"involvement":[144],"also":[146],"eligible":[147],"clinically":[149],"stable.":[150],"consists":[152],"21-day":[154],"cycles":[155],"200":[157],"mg":[158],"P":[159],"on":[160,165],"day":[161],"1":[162,167],"G":[164],"days":[166],"8.":[169],"safety":[172,224,467],"dose":[173,183],"testing,":[174],"use":[176],"standard":[178],"6+6":[179],"design":[180],"2":[182,423],"levels":[184],"(DL)":[185],"G:":[187],"1250":[188],"mg/m2":[189,193],"(DL0)":[190],"1000":[192],"(DL1).":[194],"treated":[197],"until":[198],"radiologic":[199],"symptomatic":[201],"progression,":[202],"unacceptable":[204],"toxicity.":[205],"The":[206,403],"primary":[207],"objectives":[208,220],"RP2D":[210],"objective":[212],"response":[213,238],"rate":[214,236],"(ORR)":[215],"combination;":[218],"secondary":[219],"include":[221],"evaluation":[222],"tolerability":[226],"other":[228,375],"variables":[230],"(progression-free":[231],"survival":[232,243],"[PFS],":[233],"[CBR],":[237],"duration":[239],"[RD]":[240],"overall":[242],"[OS]).":[244],"Efficacy":[245],"measured":[247,255],"by":[248,407],"RECIST":[249],"1.1.":[250],"irRECIST.":[252],"Safety":[253],"using":[256],"National":[258],"Cancer":[259,490,501],"Institute":[260],"Common":[261],"Terminology":[262],"Criteria":[263],"Adverse":[265],"Events":[266],"(NCI-CTCAE)":[267],"4.0.":[268],"As":[269],"exploratory":[270],"objectives,":[271],"immunological":[272],"biomarkers":[273],"analyzed":[275],"tumor":[277,292,340],"biopsies":[278],"blood":[280,358],"samples":[281,293,304,322,353],"correlated":[283],"(1)":[285],"(2)":[289],"disease":[290],"outcomes.Sequential":[291],"collected":[295],"at":[296,301,307,315],"baseline,":[297,308],"cycle":[298,309,312],"3":[299],"progression.":[302],"Blood":[303,352],"drawn":[306],"3,":[310],"6,":[313],"post-treatment":[316],"visit":[317],"(whatever":[318],"occurs":[319],"first).":[320],"Tumor":[321],"characterized":[324,355],"intratumoral":[326],"stromal":[328],"tumor-infiltrating":[329],"lymphocytes,":[330],"tumor-associated":[331],"macrophages":[332],"myeloid-derived":[334],"suppressor":[335],"cells,":[336],"PD-L1":[337],"expression":[338,364],"cells":[341],"stroma.":[343],"Moreover,":[344],"molecular":[345],"genetic":[347],"profiling":[348],"will":[349,384,400],"be":[350,385,401],"performed.":[351],"peripheral":[357],"mononuclear":[359],"(PBMC)":[361],"phenotype":[362],"(including":[363],"co-activatory":[366],"co-inhibitory":[368],"receptors),":[369],"cytokine":[370],"profile,":[371],"activity":[373],"immunosuppressive":[376],"pathways":[377],"(e.g.,":[378],"IDO1-dependent":[379],"tryptophan":[380],"catabolism).":[381],"These":[382],"results":[383],"compared":[386],"data":[388],"from":[389],"cohort":[391],"healthy":[393],"volunteers.":[394],"A":[395,457],"maximum":[396],"65":[398],"included.":[402],"study":[404],"approved":[406],"ethical":[409],"committee":[410],"Competent":[412],"Authority":[413],"Spain":[415],"already":[417],"open":[418],"patient":[420],"recruitment":[421],"10":[426],"participating":[427],"sites.":[428],"Keywords:":[429],"Breast":[430,489],"HER2":[431],"Immunotherapy":[434],"Citation":[435],"Format:":[436],"de":[437],"la":[438],"Cruz":[439],"L,":[440,454],"S\u00e1nchez-Margalet":[441],"V,":[442],"Berraondo":[443],"P,":[444],"Benito":[445],"S,":[446],"Escudero":[447],"MJ,":[448],"Caballero":[449],"R,":[450],"Carrasco":[451],"E,":[452],"Galluzzi":[453],"Rojo":[455],"F.":[456],"multicenter":[458],"evaluate":[463],"pembrolizumab":[469],"gemcitabine":[471],"cancer:":[478],"GEICAM/2015-04":[479],"PANGEA-Breast":[480],"[abstract].":[481],"In:":[482],"Proceedings":[483],"2017":[486,492],"San":[487,495],"Antonio":[488],"Symposium;":[491],"Dec":[493],"5-9;":[494],"Antonio,":[496],"TX.":[497],"Philadelphia":[498],"(PA):":[499],"AACR;":[500],"Res":[502],"2018;78(4":[503],"Suppl):Abstract":[504],"nr":[505],"OT1-01-02.":[506]},"counts_by_year":[{"year":2019,"cited_by_count":2}],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2018-03-29T00:00:00"}